Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and Magnesium for Sleep Quality After TJA
NCT03879707Phase 1Withdrawn
- Sponsor
- Stanford University
- Start
- Jun 2025
- Primary completion
- Jun 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative pain and sleep disorder comparing Melatonin + Magnesium with Placebo (2 arms). Primary endpoint: Effect of melatonin and magnesium on pain at 90 days. Planned start Jun 2025; status: withdrawn.
02
Drugs
melatoninmagnesium
03
Conditions
postoperative painsleep disorder
Beyond the preview
Go deeper on NCT03879707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03879707.